Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report ; volume:10 ; number:1 ; day:8 ; month:11 ; year:2016 ; pages:1-5 ; date:12.2016
Journal of medical case reports ; 10, Heft 1 (8.11.2016), 1-5, 12.2016
- Urheber
-
Sakamoto, Mito
- Beteiligte Personen und Organisationen
-
Osato, Kazuhiro
Kubo, Michiko
Nii, Masafumi
Tanaka, Hiroaki
Murabayashi, Nao
Umekawa, Takashi
Kamimoto, Yuki
Ikeda, Tomoaki
SpringerLink (Online service)
- DOI
-
10.1186/s13256-016-1098-x
- URN
-
urn:nbn:de:1111-2016120116262
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sakamoto, Mito
- Osato, Kazuhiro
- Kubo, Michiko
- Nii, Masafumi
- Tanaka, Hiroaki
- Murabayashi, Nao
- Umekawa, Takashi
- Kamimoto, Yuki
- Ikeda, Tomoaki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Creation of a long-acting nanoformulated dolutegravir
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Untersuchungen über die Entstehung von Long-acting thyroid stimulator (LATS)
Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
Recent progress in advanced biomaterials for long-acting reversible contraception
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Creation of a long-acting nanoformulated dolutegravir
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Untersuchungen über die Entstehung von Long-acting thyroid stimulator (LATS)
Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
Recent progress in advanced biomaterials for long-acting reversible contraception
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Creation of a long-acting nanoformulated dolutegravir
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Untersuchungen über die Entstehung von Long-acting thyroid stimulator (LATS)
Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
Recent progress in advanced biomaterials for long-acting reversible contraception